Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Find ways to maintain a steady income flow while managing debt. Ensure financial stability and peace of mind.
28,099 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Recruiting Insight rolls out HiringCenter Pro, an AI-enabled platform designed to automate recruitment, centralize co...
Investors chasing quantum headlines often overlook how a big subscription software player can deliver durable AI-and-...
Celebrities are dipping into hobbies beyond their screen roles, and Russell Crowe’s new TikTok habit is a case study ...
In a volatile market, a strategically chosen oil major could outperform the S&P 500 in the latter half of 2026. This ...
Investors are asking if sofi stock finally bottomed? This guide breaks down the signals, what the data actually shows...
Investors are weighing whether Chevron’s recent steps point to a new growth platform. This deep dive explains what a ...
A young professional beats the odds after a wrist injury derailed college plans, turning setback into a leadership jo...
Bitcoin trader and former BitMEX catalyst Arthur Hayes is sticking to a bold forecast: a multi-hundred-thousand-dolla...
A fresh look at how to read Lifetime Brands' Q4 2025 earnings transcript. This guide explains key metrics, growth dri...
Rivian is rolling out its smaller R2 SUV, and deliveries have begun. As investors watch the headlines, the big questi...